isovitexin has been researched along with oleanolic acid in 4 studies
Studies (isovitexin) | Trials (isovitexin) | Recent Studies (post-2010) (isovitexin) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
---|---|---|---|---|---|
123 | 0 | 81 | 4,169 | 31 | 2,404 |
Protein | Taxonomy | isovitexin (IC50) | oleanolic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
Phospholipase A2 | Homo sapiens (human) | 3 | |
DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
Tissue factor | Homo sapiens (human) | 0.005 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
Transcription factor p65 | Homo sapiens (human) | 2.4 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
Protease | Human immunodeficiency virus 1 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Jang, DS; Kim, JH; Kim, JM; Kim, JS; Kim, YS; Lee, YM; Yoo, JL | 1 |
Liu, GM; Xia, CL; Zhang, H | 1 |
Ji, XY; Li, QR; Wei, Q; Xu, F; Yin, H | 1 |
4 other study(ies) available for isovitexin and oleanolic acid
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Aldose-reductase- and protein-glycation-inhibitory principles from the whole plant of Duchesnea chrysantha.
Topics: Aldehyde Reductase; Animals; Apigenin; Ellagic Acid; Glycation End Products, Advanced; Glycosides; Lens, Crystalline; Molecular Structure; Oleanolic Acid; Quercetin; Rats; Rats, Sprague-Dawley; Rosaceae; Stereoisomerism; Structure-Activity Relationship; Triterpenes; Ursolic Acid | 2008 |
[Chemical constituents from herbs of Swertia delavayi].
Topics: Apigenin; Glucosides; Iridoid Glucosides; Iridoids; Luteolin; Magnetic Resonance Spectroscopy; Oleanolic Acid; Pyrones; Sitosterols; Spectrometry, Mass, Electrospray Ionization; Swertia | 2008 |
[Chemical Constituents from Leaves of Hibiscus syriacus and Their α-Glucosidase Inhibitory Activities].
Topics: alpha-Glucosidases; Apigenin; Glucosides; Glycoside Hydrolase Inhibitors; Hibiscus; Kaempferols; Luteolin; Oleanolic Acid; Phytochemicals; Plant Leaves; Sitosterols; Stigmasterol; Triterpenes | 2015 |